Free Trial

Lantern Pharma (LTRN) Institutional Ownership

Lantern Pharma logo
$4.12 -0.23 (-5.29%)
Closing price 04:00 PM Eastern
Extended Trading
$4.19 +0.07 (+1.72%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Lantern Pharma (NASDAQ:LTRN)

Current
Institutional Ownership
Percentage
28.62%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$4.32M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$868.76K
Get LTRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LTRN Institutional Buying and Selling by Quarter

Lantern Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025NewEdge Advisors LLC56,507$179K0.0%-5.7%0.524%
8/12/2025XTX Topco Ltd12,624$40K0.0%N/A0.117%
8/12/2025BIOS Capital Management LP1,075,952$3.40M4.7%-10.9%9.981%
8/5/2025Westside Investment Management Inc.35,900$113K0.0%+17.1%0.333%
5/16/2025NewEdge Advisors LLC59,924$212K0.0%-12.3%0.556%
4/23/2025Perigon Wealth Management LLC39,387$139K0.0%+169.8%0.365%
2/17/2025Two Sigma Investments LP16,545$53K0.0%-51.8%0.153%
2/14/2025Voss Capital LP50,000$160K0.0%N/A0.464%
2/13/2025NewEdge Advisors LLC68,359$218K0.0%-50.2%0.634%
2/13/2025Renaissance Technologies LLC87,300$278K0.0%+3.9%0.810%
2/10/2025BIOS Capital Management LP1,207,709$3.85M4.1%N/A11.203%
2/7/2025CM Management LLC200,000$638K0.6%+8.1%1.855%
1/31/2025Sanctuary Advisors LLC10,000$32K0.0%N/A0.093%
1/24/2025DAVENPORT & Co LLC25,814$82K0.0%-52.0%0.239%
1/22/2025Perigon Wealth Management LLC14,600$47K0.0%-49.5%0.135%
11/20/2024Westside Investment Management Inc.30,650$112K0.0%+166.5%0.284%
8/9/2024Renaissance Technologies LLC81,800$382K0.0%+24.5%0.760%
8/9/2024Dimensional Fund Advisors LP18,413$86K0.0%+55.7%0.171%
8/2/2024CM Management LLC80,000$374K0.3%+23.1%0.743%
7/17/2024Westside Investment Management Inc.11,500$54K0.0%N/A0.107%
5/14/2024CM Management LLC65,000$572K0.5%-18.8%0.604%
5/10/2024Tocqueville Asset Management L.P.19,000$167K0.0%N/A0.177%
4/10/2024Pathway Financial Advisors LLC25,001$220K0.1%-12.3%0.233%
2/12/2024Redmond Asset Management LLC40,662$174K0.1%-12.6%0.374%
2/8/2024Meridian Wealth Management LLC19,660$84K0.0%+18.0%0.181%
2/1/2024Sigma Planning Corp11,875$51K0.0%-34.5%0.109%
2/1/2024Pathway Financial Advisors LLC28,501$122K0.0%-13.0%0.262%
10/30/2023Pathway Financial Advisors LLC32,771$112K0.0%+134.1%0.302%
10/17/2023Meridian Wealth Management LLC16,660$57K0.0%N/A0.153%
8/10/2023Carlson Capital L P95,000$536K0.0%-23.9%0.875%
8/4/2023CM Management LLC75,000$423K0.4%+25.0%0.691%
7/19/2023Pathway Financial Advisors LLC14,001$79K0.0%N/A0.129%
2/9/2023CM Management LLC60,000$362K0.4%+20.0%0.552%
2/9/2023Wolff Wiese Magana LLC27,098$164K0.1%-11.0%0.250%
2/7/2023Lynwood Capital Management Inc.12,000$73K0.1%N/A0.110%
11/15/2022Carlson Capital L P168,000$803K0.1%-1.2%1.547%
11/4/2022CM Management LLC50,000$239K0.3%+10.9%0.462%
8/8/2022CM Management LLC45,100$258K0.3%+33.6%0.416%
7/15/2022Wolff Wiese Magana LLC31,575$180K0.1%-12.7%0.292%
7/11/2022Sanders Morris Harris LLC366,030$2.06M0.5%-4.7%3.379%
5/9/2022CM Management LLC33,765$241K0.2%N/A0.312%
5/9/2022Wolff Wiese Magana LLC36,155$259K0.2%+5.9%0.334%
4/11/2022Sanders Morris Harris LLC384,228$2.75M0.5%+14.2%3.564%
2/4/2022Envestnet Asset Management Inc.10,542$84K0.0%N/A0.094%
2/4/2022Redmond Asset Management LLC49,187$393K0.1%+3.7%0.440%
2/3/2022Advisor Group Holdings Inc.5,331$43K0.0%+92.5%0.048%
2/2/2022Sanders Morris Harris LLC336,425$2.57M0.4%N/A3.007%
2/2/2022Sigma Planning Corp17,600$140K0.0%N/A0.157%
1/14/2022Spire Wealth Management4,050$32K0.0%+285.7%0.036%
11/9/2021BlackRock Inc.23,074$258K0.0%-8.1%0.206%
11/5/2021Advisor Group Holdings Inc.2,770$31K0.0%+177.0%0.025%
11/2/2021Raymond James & Associates25,879$289K0.0%N/A0.231%
10/29/2021GWM Advisors LLC155,859$1.74M0.0%+3.0%1.394%
10/22/2021Redmond Asset Management LLC47,442$530K0.2%+4.3%0.424%
10/15/2021Wolff Wiese Magana LLC35,316$395K0.3%+24.7%0.316%
8/16/2021Corriente Advisors LLC656,364$9.58M5.2%-8.0%5.869%
8/13/2021Geode Capital Management LLC55,479$809K0.0%+21.1%0.496%
8/13/2021Vanguard Group Inc.269,429$3.93M0.0%+4.0%2.409%
8/11/2021Bank of New York Mellon Corp26,765$391K0.0%+127.3%0.239%
(Data available from 1/1/2016 forward)

LTRN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LTRN shares?

During the previous two years, 17 institutional investors and hedge funds held shares of Lantern Pharma. The most heavily invested institutionals were BIOS Capital Management LP ($3.40M), CM Management LLC ($638K), Renaissance Technologies LLC ($278K), Pathway Financial Advisors LLC ($220K), NewEdge Advisors LLC ($179K), Redmond Asset Management LLC ($174K), and Tocqueville Asset Management L.P. ($167K).Learn more on Lantern Pharma's institutional investors.

What percentage of Lantern Pharma's stock is owned by institutional investors?

28.62% of Lantern Pharma's stock is owned by institutional investors. Learn more on LTRN's institutional investor holdings.

Which institutional investors have been buying Lantern Pharma's stock?

Of the 12 institutional investors that purchased Lantern Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($1.21M), Voss Capital LP ($50K), Westside Investment Management Inc. ($35.90K), CM Management LLC ($30K), Perigon Wealth Management LLC ($24.79K), Meridian Wealth Management LLC ($19.66K), and Renaissance Technologies LLC ($19.40K).

How much institutional buying is happening at Lantern Pharma?

Institutional investors have bought a total of 1,347,820 shares in the last 24 months. This purchase volume represents approximately $4.32M in transactions.

Which of Lantern Pharma's major shareholders have been selling company stock?

The following institutional investors have sold Lantern Pharma stock in the last 24 months: BIOS Capital Management LP ($131.76K), NewEdge Advisors LLC ($80.83K), DAVENPORT & Co LLC ($28K), Two Sigma Investments LP ($17.80K), and Perigon Wealth Management LLC ($14.30K).

How much institutional selling is happening at Lantern Pharma?

Institutional investors have sold a total of 272,683 shares in the last 24 months. This volume of shares sold represents approximately $868.76K in transactions.



This page (NASDAQ:LTRN) was last updated on 10/1/2025 by MarketBeat.com Staff
From Our Partners